BrightEdge's book
17 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | — | |
| Paradigm Health (Healthcare Technology Systems) | Other Healthcare Technology Systems | $443.0M | — | — | |
| Thatch | — | $410.0M | — | — | |
| CellCentric | Biotechnology | $382.5M | — | — | |
| Interius BioTherapeutics | — | $350.0M | — | — | |
| Clasp Therapeutics | — | $191.5M | — | — | |
| Alpheus Medical | — | $140.0M | — | — | |
| Mercy BioAnalytics | — | $122.0M | — | — | |
| Auron Therapeutics | — | $106.3M | — | — | |
| Catena Labs | — | $82.0M | — | — | |
| + 7 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 17 recorded positions
- ·Watchlist + alerts for BrightEdge's activity
Create free account
No card required